52544-694 : 24 Hr Matzim 360 mg Extended Release Tablet


NDC52544-694
Labeler: Watson Pharma, Inc.
Product Type: Human Prescription Drug
Drug Name:  Matzim La
Dosage Form: Oral Tablet, Extended Release
Application #: ANDA077686
Rev. Date: 


Appearance:


Markings: 360;694
Shapes:  Oval
Colors:  White
Size (mm): 19
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

360 694: (52544-694) 24 Hr Matzim 360 mg Extended Release Tablet by Watson Pharma, Inc.
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 52544-694-10: 1000 TABLET, EXTENDED RELEASE IN 1 BOTTLE, PLASTIC (52544‑694‑10)
  • 52544-694-19: 90 TABLET, EXTENDED RELEASE IN 1 BOTTLE, PLASTIC (52544‑694‑19)
  • 52544-694-30: 30 TABLET, EXTENDED RELEASE IN 1 BOTTLE, PLASTIC (52544‑694‑30)

Active Ingredients:

  • Diltiazem Hydrochloride

Dosage Strength:

  • 360 mg

Inactive Ingredients:

  • Candelilla Wax
  • Silicon Dioxide
  • Starch, Corn
  • Ethylcelluloses
  • Hypromellose 2910 (5 Mpa.s)
  • Lactose Monohydrate
  • Magnesium Stearate
  • Cellulose, Microcrystalline
  • Nonoxynol-100
  • Polyethylene Glycols
  • Polysorbate 80
  • Povidone K30
  • Sucrose
  • Talc
  • Titanium Dioxide
  • Triacetin
  • Hypromellose 2910 (15 Mpa.s)
  • Ethyl Acrylate and Methyl Methacrylate Copolymer (2:1; 600000 Mw)

Pharmaceutical Classes:

  • Calcium Channel Antagonists [MoA]
  • Calcium Channel Blocker [EPC]

Related Products:

Based on records with the same trade name.
  • 52544-690 24 Hr Matzim 120 mg Extended Release Tablet by Watson Pharma, Inc.
  • 52544-691 24 Hr Matzim 180 mg Extended Release Tablet by Watson Pharma, Inc.
  • 52544-692 24 Hr Matzim 240 mg Extended Release Tablet by Watson Pharma, Inc.
  • 52544-693 24 Hr Matzim 300 mg Extended Release Tablet by Watson Pharma, Inc.
  • 52544-695 24 Hr Matzim 420 mg Extended Release Tablet by Watson Pharma, Inc.
  • 70518-1950 Matzim La 180 mg Oral Tablet, Extended Release by Remedyrepack Inc.
  • 70518-2270 Matzim La 240 mg Oral Tablet, Extended Release by Remedyrepack Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 52544-694 QR Code

< Prev: 52544-693Next: 52544-695 >

Related Discussions:

Diltiazem CD, XR & ER
What is the difference between diltiazem CD, diltiazem XR and diltiazem ER? Can you refer me to a website where I could ... 76 replies
Diltiazem Hydrochloride Extended Release Capsules
Not sure what they are for. ## How long does it take for diltia XT 180mg to leave your system and side effects to subsid... 8 replies
diltiazem cd er
I have been told by my Neurologist that this drug Diltiazem cd can cause Parkinson like symptoms in a small group of peo... 8 replies
Diltiazem (inwood)
Im taking diltiazem (inwood)240 mg sa cap and im having something like a rash on my face and my eyes have been bothering... 8 replies
Diltiazem - 120mg - Tired and Fatigued
I have been on this drug for 6 months due to an AFIB episode. Before taking this medication I was never likely to nap or... 7 replies
Diltiazem lingering side effects
How long does it take for the side effects to go away after discontinuing the drug? I stopped it one week ago and contin... 5 replies
Diltiazem xt 180 mg
Has anyone had the reddening of the skin due to peripheral vaso dilation, if so when med. Was discontinued did it subsid... 5 replies
Diltiazem 240mg C Cap Acta
I need the side effects of this high blood pressure drug ## Diltiazem is a calcium channel blocker, so it may cause side... 5 replies
Diltiazem ER 180 to 240 dose
Hello, I am taking the 180 and about to run out, and have some 240 mgs left. Can i take them until my 180s get filled? W... 3 replies
Diltiazem 120mg tablets vs capsules
Is there a difference between the drug Diltiazem 120mg taking tablets or capsules? ## Wow! Here was a really personal qu... 3 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.